ACI Limited
Dapagliflozin Diabetes & metabolic
Originator: Forxiga · AstraZeneca (originally developed with Bristol-Myers Squibb)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Glycema | 5 mg, 10 mg | — | — | — | — |
| Glycema | 5 mg | Tablet | BDT 20 | US$0.16 | 3 x 10: ৳ 600.00 |
| Glycema | 10 mg | Tablet | BDT 30 | US$0.24 | 2 x 10: ৳ 600.00 |
Empagliflozin Diabetes & metabolic
Originator: Jardiance · Boehringer Ingelheim, co-marketed with Eli Lilly and Company (licensed from Boehringer Ingelheim International GmbH)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Coport | 10 mg | Tablet | BDT 25 | US$0.20 | 3 x 10: ৳ 750.00 |
| Coport | 25 mg | Tablet | BDT 45 | US$0.37 | 3 x 10: ৳ 1,350.00 |
Insulin Glargine Diabetes & metabolic
Originator: Lantus · Sanofi
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Glarine | 100 IU/ml | SC Injection | — | — | 3's pack: ৳ 2,400.00 |
Linagliptin Diabetes & metabolic
Originator: Tradjenta · Boehringer Ingelheim (marketed in the US by Boehringer Ingelheim Pharmaceuticals, Inc.; co-promoted with Eli Lilly in several markets)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Glitin | 5 mg | Tablet | BDT 25 | US$0.20 | 3 x 10: ৳ 750.00 |
Rituximab Cancer (oncology)
Originator: Rituxan · Genentech, Inc. (a member of the Roche Group), with Biogen; Rituxan is jointly marketed by Biogen and Genentech USA in the US; MabThera is marketed by Roche
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Mabrix | 10 mg/mL, 100 mg and 500 mg vials | — | — | — | — |
| Mabrix | 10 mg/ml | IV Infusion | — | — | — |
Sitagliptin Diabetes & metabolic
Originator: Januvia · Merck Sharp & Dohme (MSD), a subsidiary of Merck & Co., Inc.
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Sitap | 50 mg and 100 mg tablets | — | — | — | — |
| Sitap | 100 mg | Tablet | BDT 28.08 | US$0.23 | 1 x 10: ৳ 280.80 |
| Sitap | 50 mg | Tablet | BDT 18 | US$0.15 | 3 x 10: ৳ 540.00 |
Sofosbuvir/Velpatasvir Antivirals (hepatitis C)
Originator: Epclusa · Gilead Sciences (Gilead Sciences Ireland UC for the EU)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Sovel | 400 mg + 100 mg tablet | — | — | — | — |
| Sovel | 400 mg+100 mg | Tablet | BDT 1,000 | US$8.14 | 1 x 7: ৳ 7,000.00 |
Tofacitinib Immunology & rheumatology
Originator: Xeljanz / Xeljanz XR · Pfizer (initial U.S. approval 2012)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Tofara | 5 mg | Tablet | BDT 47 | US$0.38 | 3 x 10: ৳ 1,410.00 |
Vildagliptin Diabetes & metabolic
Originator: Galvus · Novartis
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Aptin | 50 mg tablet | — | — | — | — |
| Aptin | 50 mg | Tablet | BDT 22 | US$0.18 | 3 x 10: ৳ 660.00 |
This page is an information resource for healthcare professionals, licensed importers and patients under medical care. It is not medical advice, not a prescription service, and not an offer to sell prescription medicines to the public.
Need a verified quotation?
Send us the molecule, strength, pack size, quantity and destination country. We reply with a batch-traceable quotation, certificates of analysis and shipping documentation.
We supply licensed pharmacies, hospitals, importers and distributors — not direct-to-consumer patients.